{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:24:16Z","timestamp":1790889856925,"version":"4.1.0"},"reference-count":30,"publisher":"American Physiological Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Gastrointestinal and Liver Physiology"],"published-print":{"date-parts":[[2004,9]]},"abstract":"<jats:p>Alcoholic liver disease (ALD) remains a leading cause of death from liver disease in the United States for which there is no FDA-approved therapy. Abnormal cytokine metabolism is a major feature of ALD. Elevated serum concentration levels of TNF-\u03b1 and TNF-\u03b1-inducible cytokines\/chemokines, such as IL-6, -8, and -18, have been reported in patients with alcoholic hepatitis and\/or cirrhosis, and levels correlated with markers of the acute phase response, liver function, and clinical outcome. Studies in animal models support an etiologic role for cytokines in the liver injury of ALD. Cytokines, such as transforming growth factor-\u03b2, play a critical role in the fibrosis of ALD. Multiple new strategies are under investigation to modulate cytokine metabolism as a form of therapy for ALD.<\/jats:p>","DOI":"10.1152\/ajpgi.00171.2004","type":"journal-article","created":{"date-parts":[[2004,8,26]],"date-time":"2004-08-26T22:33:32Z","timestamp":1093559612000},"page":"G497-G502","source":"Crossref","is-referenced-by-count":192,"title":["Recent Advances in Alcoholic Liver Disease IV. Dysregulated cytokine metabolism in alcoholic liver disease"],"prefix":"10.1152","volume":"287","author":[{"given":"Craig J.","family":"McClain","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Louisville Medical Center, Louisville, Kentucky 40292"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyuan","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Louisville Medical Center, Louisville, Kentucky 40292"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirish S.","family":"Barve","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Louisville Medical Center, Louisville, Kentucky 40292"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniell B.","family":"Hill","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Louisville Medical Center, Louisville, Kentucky 40292"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ion","family":"Deaciuc","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Louisville Medical Center, Louisville, Kentucky 40292"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"24","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840170620"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1016\/S1521-6918(03)00053-2"},{"key":"R2A","unstructured":"Cabre E, Rodriguez-Iglesias P, Caballeria J, Quer JC, Sanchez-Lombrana JL, Pares A, Papo M, Planas R, Gassull MA, and the Spanish Group for the Study of Alcoholic Hepatitis.Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial.Hepatology32: 36\u201342, 2000."},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50472"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1126\/science.1071924"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70034-4"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)00116-1"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Fausto N.Liver regeneration.J Hepatol32,Suppl1: 19\u201331, 2000.","DOI":"10.1016\/S0168-8278(00)80412-2"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260119"},{"key":"R9","unstructured":"Hill D, Shedlofsky S, McClain CJ, Diehl AM, and Tsukamoto H.Cytokines and liver disease. In:Cytokines in Health and Disease, edited by Remick D and Friedland J (2nd ed.). New York: Dekker, 1997, p. 401\u2013425."},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Hill DB, Schmidt J, Shedlofsky S, Cohen D, and McClain CJ.In vitro tumor necrosis factor cytotoxicity in HepG2 liver cells.Hepatology21: 1114\u20131119, 1995.","DOI":"10.1002\/hep.1840210434"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1992.tb00656.x"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260621"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50470"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Kamimura Sand Tsukamoto H.Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease.Hepatology21: 1304\u20131309, 1995.","DOI":"10.1002\/hep.1840220441"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, and Wendel A.Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-\u03b1 requires transcriptional arrest.J Immunol153: 1778\u20131788, 1994.","DOI":"10.4049\/jimmunol.153.4.1778"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1002\/bies.10204"},{"key":"R16A","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80263-3"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007110"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840090302"},{"key":"R18A","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.04034.x"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Nanji AA, Zhao S, Sadrzadeh SM, and Waxman DJ.Use of reverse transcription-polymerase chain reaction to evaluate in vivo cytokine gene expression in rats fed ethanol for long periods.Hepatology19: 1483\u20131487, 1994.","DOI":"10.1016\/0270-9139(94)90246-1"},{"key":"R19A","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20206"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1053\/he.2000.7013"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.10.7.8635688"},{"key":"R21A","unstructured":"Song Z, Zhou Z, Uriarte S, Wang L, Kang JY, Chen T, Barve S, and McClain CJ.S-adenosylhomocysteine sensitizes to tumor necrosis factor hepatotoxicity: A possible etiologic factor in alcoholic liver disease.HepatologyIn press."},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5288.784"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.1.1"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70354-9"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Zhang Z, Bagby GJ, Stoltz D, Oliver P, Schwarzenberger PO, and Kolls JK.Prolonged ethanol treatment enhances lipopolysaccharide\/phorbol myristate acetate-induced tumor necrosis factor-\u03b1 production in human monocytic cells.Alcohol Clin Exp Res25: 444\u2013449, 2001.","DOI":"10.1111\/j.1530-0277.2001.tb02233.x"}],"container-title":["American Journal of Physiology-Gastrointestinal and Liver Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/ajpgi.00171.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T07:14:14Z","timestamp":1682752454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/ajpgi.00171.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["10.1152\/ajpgi.00171.2004"],"URL":"https:\/\/doi.org\/10.1152\/ajpgi.00171.2004","relation":{},"ISSN":["0193-1857","1522-1547"],"issn-type":[{"value":"0193-1857","type":"print"},{"value":"1522-1547","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}